VENUNGOPAL, P., BALAKRISHNAN, K., SRIRAM, D.K. and GEORGE, M. 2022. INCLISIRAN (LEQVIO): A FIRST-IN-CLASS SMALL INTERFERING RNA THERAPEUTIC DRUG APPROVED BY FDA FOR TREATING PRIMARY HYPERCHOLESTEROLEMIA OR DYSLIPIDEMIA. Asian Journal of Pharmaceutical and Clinical Research. 15, 12 (Dec. 2022), 42–46. DOI:https://doi.org/10.22159/ajpcr.2022.v15i12.46054.